Background {#Sec1}
==========

Tuberculosis (TB) is a global infectious disease in humans. It is a severe and even lethal disease and was responsible for 1.2 million deaths worldwide in 2018 \[[@CR1]\]. The main reason worldwide TB eradication is so difficult is that smear-positive TB patients are the most important source of infection. They often transmit the TB bacterium via droplets produced by coughing, sneezing, etc. It was found that a TB patient typically infects 10--15 people from the onset of the disease until diagnosis and treatment and that these infected people can, in turn, become new sources of infection. A healthy person's chances of being infected with *Mycobacterium tuberculosis* depend on the number of droplets inhaled and duration as well as the individual's immune status.

It is well known that approximately one-third of the world's population is infected with *M. tuberculosis* \[[@CR1]\], whereas only 10% of these infected individuals progress to TB disease \[[@CR2]\]. This indicates that the risk of developing TB in humans is strongly associated with host-pathogen interactions, the environment, and genetic background \[[@CR3]\]. Recently, a growing number of studies has supported the hypothesis that TB risk is associated with polymorphisms of immune- and inflammation-related genes (IIRGs), including the interleukin-10 (*IL-10*), *IL1A*, *IL1B, IL6*, *IL12B*, *IL27*, interleukin 12 receptor beta 1 (*IL12RB1*), interleukin 18 receptor 1 (*IL18R1*), signal transducer and activator of transcription 1 (*STAT1*), natural resistance-associated macrophage protein 1 (*SLC11A1* or *NRAMP1*), *SP110*, lymphotoxin A (*LTA*), tumor necrosis factor (*TNF*), interferon gamma receptor 1 (*IFNGR1*), *IFNGR2*, mannose-binding lectin 2 (*MBL2*), vitamin D receptor (*VDR*), monocyte chemoattractant protein-1 (*MCP-1* or *CCL2*), and toll-like receptor 8 (*TLR8*) genes \[[@CR4]--[@CR13]\]. IIRGs play essential roles in innate and adaptive immunity, which help control *M. tuberculosis* infection in humans \[[@CR14]\]. Therefore, polymorphisms in these genes can alter immunity and lead to genetic susceptibility to TB. Moreover, common genetic variants of IIRGs could be used to predict and evaluate TB risk in the early stages of infection.

However, previous studies have mostly focused on the association between polymorphisms in one or several related genes and susceptibility to TB, rather than multiple IIRGs. It is well known that the interaction between *M. tuberculosis* and its host leads to a very complex immune response. As such, studies that focus on a single or a small number of sample genes may overlook potential associations between multiple genes: for example, they may ignore linkage disequilibrium between numerous single-nucleotide polymorphisms (SNPs). Therefore, it is imperative to study the association between various SNPs and susceptibility to TB in as many IIRGs as possible.

In this study, 64 SNPs in 18 IIRGs were selected, and the association between these SNPs and TB risk was evaluated using the polymerase chain reaction (PCR)-MassArray method in a large case-control population of Han Chinese origin.

Methods {#Sec2}
=======

Patients, controls, and ethics statement {#Sec3}
----------------------------------------

This case-control study was performed in the 8th Medical Center of Chinese PLA General Hospital (Beijing, China) from June 2009 to March 2019 and was approved by the Research Ethics Committee of the 8th Medical Center of the Chinese PLA General Hospital. All DNA samples were extracted from residual blood after a liver function test. Informed consent was obtained from all participants. In total, 1016 patients (597 males and 419 females, mean age 39.5 ± 19.3 years) with a TB diagnosis according to smear, *M. tuberculosis* culture, radiological examination, and histological examination were randomly included from the patients in the 8th Medical Center of the Chinese PLA General Hospital (Beijing, China). In the same period, 507 healthy volunteers (289 males and 218 females, mean age 51.8 ± 10.6 years) with retrospectively confirmed non-tuberculous diseases were included from the physical examination center of 8th Medical Center of the Chinese PLA General Hospital. All TB and control patients were HIV negative.

DNA extraction {#Sec4}
--------------

Blood samples (2 ml) from each participant were collected (the residual portion of the blood samples obtained for a liver function test) and stored in citrate-anticoagulated glass tubes at − 40 °C until use. The Whole Blood DNA Extraction Kit (Tiangen Biotech, Co., Ltd., Beijing, China) was used to extract total genomic DNA from 1 ml of the stored blood samples, following the manufacturer's instructions. Then, the extracted genomic DNA was resuspended in 0.1 × Tris-EDTA buffer (10 mmol/L Tris, 1 mmol/L EDTA, pH 8.0) and stored at − 20 °C.

Screening of target SNPs {#Sec5}
------------------------

Data from the International HapMap Project (<http://hapmap.ncbi.nlm.nih.gov>) were used to screen potential SNPs using an estimated *r*^2^ threshold of \> 0.8 for the untyped SNPs as reported in a previous study \[[@CR15]\]. The genotype data for the Han Chinese population were obtained from the Haploview 4.2 program (<http://www.broad.mit.edu/haploview>) and used to select SNPs that have a minor allele frequency (MAF) of \> 0.05.

Genotyping {#Sec6}
----------

In total, 64 SNPs of *IL-10*, *IL18R1*, *IL1A*, *IL1B*, *STAT1*, *SLC11A1*, *SP110*, *IL12B*, *LTA*, *TNF*, *IFNGR1*, *MBL2*, *VDR*, *IL27*, *CCL2*, *IL12RB1*, *IFNGR2*, and *TLR8* were genotyped in samples from both TB patients and controls using the iPLEX assay on a MassArray system (Sequenom Inc., San Diego, United States) according to a previously published protocol \[[@CR16]\]. The main particularities are listed below: (1) PCR reactions: Genomic DNA (10 ng), *Taq* DNA polymerase (0.5 U, HotStarTaq, Qiagen, Shanghai, China), dNTPs (500 μmol), and PCR primers (100 nmol) in a 5-μl reaction volume were added into a 384-well plate. Then, PCR thermal cycling was performed at 94 °C, followed by 45 cycles of 20 s at 94 °C, 30 s at 56 °C, and 60 s at 72 °C using an ABI-9700 instrument (Thermo Fisher Scientific Inc., Waltham, United States). Finally, the PCR products were examined by 2.0% agarose gel electrophoresis. (2) Purification: After the PCR reaction, 2 μl of shrimp alkaline phosphatase (0.3 U) was mixed with the PCR products, incubated at 37 °C for 20 min, and then inactivated at 85 °C for 5 min. (3) Extension: The concentrations of the extension primers were adjusted to equilibrate the signal-to-noise ratios. Then, termination mix (100 μmol), DNA polymerase (0.05 U, Sequenom, Inc., San Diego, United States), and extension primers (625 to 1250 nmol/L) in a final volume of 9 μl were pooled together and detected using an iPLEX Gold Kit (Sequenom, Inc., San Diego, United States) at 94 °C for 30 s, followed by 5 s at 94 °C and 5 cycles of 5 s at 52 °C and 5 s at 80 °C. An additional 40 annealing and extension cycles were then performed, with 5 s at 94 °C and 5 cycles of 5 s at 52 °C and 5 s at 80 °C. The final extension was carried out at 72 °C for 3 min; then, the sample was cooled to 4 °C. (4) MALDI-TOF-MS: The samples were then manually desalted using 6 mg of clean resin and a dimple plate and subsequently transferred to a 384-well Spectro-CHIP (Sequenom, Inc., San Diego, United States) using a nano-dispenser. The mass spectra were acquired using the Compact Mass Spectrometer and analyzed via the MassArray Typer 4.0 Software (Sequenom, Inc., San Diego, United States). The PCR assay was performed with two no-template controls and four duplicated samples in each 384-well format as quality controls. Each genotyping result was generated and analyzed by laboratory staff who were unaware of the patient's status.

Statistical analyses {#Sec7}
--------------------

All statistical analyses were performed using the Stata statistical package (version 10.0; StataCorp LP, College Station, TX, USA), and all *P* values were two-tailed. The *statistical* differences in allele and genotype frequencies between the TB and control groups were evaluated using the *χ*^2^-test. In the *χ*^2^-test, *P* values with a Bonferroni correction of \< 0.05 were considered significant. The Hardy-Weinberg Equilibrium (HWE) was tested via the *χ*^2^-test for goodness of fit using a web program (<http://ihg.gsf.de/cgi-bin/hw/hwa1.pl>). Moreover, Akaike's information criterion was used to select the genetic model with maximum parsimony for each SNP. Odds ratios (*OR*s) as well as 95% confidence intervals (*CI*s) were calculated via unconditional logistic regression analysis with adjustment for age and gender.

The pairwise linkage disequilibrium (LD) among the SNPs was determined using Lewontin's standardized coefficient D' and LD coefficient *r*^2^ as described in a previous study \[[@CR17]\], whereas haplotype blocks were defined in Haploview 4.2 (<https://www.broadinstitute.org/haploview/haploview>) with default settings following the criteria published in a previous study \[[@CR18]\]. In addition, the haplotype frequencies were estimated using the PHASE 2.1 Bayesian algorithm \[[@CR19]\] and HAPLO.STATS \[[@CR20]\]. The haplotypes were then pooled into a combined group if their frequency was less than 0.03. Empirical *P* values, based on 100 000 simulations, were computed for the global score test and each of the haplotype-specific score tests. The diplotype (haplotype dosage, an estimate of the number of copies of the haplotype) was the most probable haplotype pair for each individual. Unconditional logistic regression analysis was used to evaluate the *OR*s and 95% *CI*s for participants carrying 1 to 2 copies versus 0 copies of each common haplotype for the dichotomized diplotypes.

Results {#Sec8}
=======

The distribution of 64 SNP alleles in TB patients and healthy controls {#Sec9}
----------------------------------------------------------------------

One thousand and sixteen patients with a TB diagnosis and 507 healthy controls were recruited. Among the TB patients, 680 (66.9%) had total pulmonary TB (TPTB), including 388 with simple PTB and 74 with simple TB pleurisy (TBP), 166 (16.3%) had extrapulmonary TB (EPTB), and 170 (16.7%) had concomitant PTB and EPTB (PTB + EPTB).

Sixty-four SNPs from 18 IIRGs were selected and genotyped, and all allele distributions in the control group were consistent with those from the HWE (*P* \> 0.01, Table [1](#Tab1){ref-type="table"}). The results showed that the allele distributions of *LTA* rs2229094\*C (*P* = 0.015), *MBL2* rs2099902\*C (*P* = 0.001), *MBL2* rs930507\*G (*P* = 0.004), *MBL2* rs10824793\*G (*P* = 0.004), and *IL12RB1* rs2305740\*G (*P* = 0.040) were significantly different between the TB patients and healthy controls (Table [1](#Tab1){ref-type="table"}), whereas the allele distributions of the other SNPs were not. Table 1Information about 64 genotyped SNPs in the *IL-10, IL18R1, IL1A, IL1B, STAT1, SLC11A1, SP110, IL12B, LTA, TNF, IFNGR1, MBL2, VDR, IL27, CCL2, IL12RB1, IFNGR2,* and TLR8Gene: locus and OMIM No.^a^No.SNP_IDChromosome No.Chromosome position ^b^Intermarker distances ^c^ (bp)Genic locationBase ChangeMAF ^d^*P*^f^*P* value for HWE ^g^ testGenotyping rate ^h^(%)NCBI ^e^ControlTuberculosisIL10: 1q31-q32 OMIN: 1240921rs30244961206 768 519--3'UTRT → C0.00970.0510.0490.7300.546799.72rs18008711206 773 2894770IntronT → C0.25730.3640.3410.2260.509898.73rs18008961206 773 552263IntronA → G0.03400.0920.0920.9640.8843100IL18R1: 2q12 OMIN: 6044941rs37711672102 369 728--IntronT → C0.04850.0350.0350.9020.42031002rs19746752102 369 915187IntronC → T0.14560.1360.1260.4350.877399.83rs67589362102 374 9094994IntronG → A0.16990.1420.1410.9440.680999.84rs67500202102 378 2543345IntronG → A0.48060.4590.4420.3760.135099.65rs10351302102 384 9426688Exon 6 F251FG → A0.34950.3170.2990.3010.104599.56rs37711582102 393 4348492IntronT → C0.09710.0970.0880.4390.725899.7IL1A: 2q14 OMIN: 1477601rs175612112 779 646--Exon 4 A114SG → T0.06310.1210.0980.0630.882199.62rs37835262112 784 2304584IntronA → G0.36890.3510.3670.3740.012999.3IL1B: 2q14 OMIN: 1477201rs28535502112 829 54445 314IntronC → T0.08250.1110.1120.9130.148799.92rs11436332112 832 8903346IntronA → G0.41260.4350.4260.6580.566798.93rs11436272112 836 8103920UTR-5T → C0.45630.4970.4890.6850.787897.0STAT1: 2q32.2 OMIN: 6005551rs22802352190 979 104--IntronC → T0.46600.4840.4650.3350.294198.72rs168331552190 996 65117 547IntronC → T0.02910.0530.0540.9820.698199.93rs130292472191 001 9325281IntronC → T0.50000.4760.4620.4630.072898.84rs75769842191 003 8571925IntronC → A0.16500.1670.1600.6470.214099.75rs20668022191 009 9416084Exon 1 L21LT → C0.24270.2180.2100.6200.297399.2SLC11A1: 2q35 OMIN: 6002661rs22766312218 384 290--Exon 2 F66FG → A0.14080.1440.1490.6650.383499.22rs172219592218 387 9073617Exon 7 G249GC → T0.10680.0990.1120.2950.984295.43rs172354092218 395 0097102Exon 14 D543NG → A0.14080.1380.1250.3110.552999.1SP110: 2q37.1 OMIN: 6044571rs97839922230 170 873--IntronT → C0.00490.0020.0020.9890.964599.92rs101656852230 174 8824009IntronG → A0.12620.1590.1570.8450.698199.83rs9576832230 178 6603778IntronT → C0.37380.4560.4450.5660.151698.74rs413453442230 200 21221 552IntronC → G0.27180.1700.1850.3220.437498.55rs13657762230 207 9947781Exon 7 G305RA → G0.10680.1260.1140.3510.418499.6IL12B: 5q31.1-q33.1 OMIN: 1615611rs13684395159 315 006--3'URTT → G0.00970.0040.0030.4960.928999.82rs9197665159 320 5565550IntronA → C0.04370.0520.0530.9010.72831003rs32122175159 328 1227566IntronG → C0.44170.4550.4270.1450.176199.64rs25468925159 328 467345IntronG → A0.18450.1860.2120.1010.883996.5LTA: 6p21.3 OMIN: 1534401rs2009658631 570 467--IntronC → G0.18450.1440.1710.0570.374199.42rs1800683631 572 29418275'UTRG → A0.41750.4380.4200.3420.583198.73rs2229094631 572 779485Exon 1 C13RT → C0.22820.1900.229**0.015**0.173299.34rs2229092631 572 980201Exon 2 H51PA → C0.02430.0210.0240.6310.087199.95rs1041981631 573 00727Exon 2 T60NC → A0.41750.4370.4190.3490.654599.0TNF: 6p21.3 OMIN: 1911601rs1800629631 575 2542247IntronG → A0.09220.0540.0690.1000.173599.52rs3093662631 576 4121158IntronA → G0.03400.0380.0480.1830.727699.3IFNGR1: 6q23.3 OMIN: 1074701rs18874156137 198 101--Exon 7 L467PT → C0.01940.0290.0310.7430.505699.72rs22347116137 219 38321 2825'UTRC → T0.47570.4530.4480.8110.233699.3MBL2: 10q11.2 OMIN: 1545451rs20999021052 766 089--3'UTRT → C0.26700.1980.255**0.001**0.438699.32rs9305071052 768 5062417Exon 4 L126LC → G0.24270.1910.237**0.004**0.899297.13rs108247931052 769 7201214IntronA → G0.33980.2850.336**0.004**0.996699.94rs79165821052 773 2353515IntronT → C0.14560.1110.1260.2320.694999.6VDR: 12q13.11 OMIN: 6017691rs22391841247 850 800--IntronC → T0.29130.2790.2710.6370.875399.82rs22480981247 859 5738773IntronT → C0.26210.2920.2810.5190.202899.73rs15403391247 863 5433970IntronA → G0.26700.2890.3160.1240.371599.74rs107832191247 901 70538 162IntronA → T0.41750.4330.4650.1100.411994.35rs71391661247 906 5514846IntronC → G0.02430.0280.0270.8520.522199.9IL27: 16p11 OMIN: 6082731rs1812061628 502 082--Exon 4 L119RT → C0.14560.1360.1290.6210.384499.0CCL2: 17q11.2-q12 OMIN: 1581051rs45861634 256 250--Exon 2 C35CC → T0.36410.4120.3800.0920.951899.1IL12RB1: 19p13.1 OMIN: 6016041rs23057401918 069 426--IntronA → G0.09220.1360.110**0.040**0.788099.92rs4015021918 069 603177Exon 11 G378RC → G0.33500.3690.3440.1860.533499.83rs3759471918 069 64138Exon 11 M365TA → G0.33500.3680.3420.1640.475599.54rs178526351918 075 7656124Exon 7 P228PG → A0.33500.3680.3320.0550.615299.15rs115759341918 075 80843Exon 7 Q214RA → G0.33500.3750.3390.0510.966898.8IFNGR2: 21q22.11 OMIN: 1475691rs10592932133 437 386--3'URTT → C0.15530.1210.1140.5780.017999.5TLR8: Xp22 OMIN: 3003661rs3764880X12 906 707--Exon 1 M1VG → A0.17780.1530.1550.917--99.52rs5744068X12 916 93910 232IntronC → T0.22500.0170.0190.667--99.93rs2159377X12 919 3942455Exon 2 D136DT → C0.28130.2100.2050.771--99.34rs5744080X12 919 685291Exon 2 H233QT → C0.23130.1940.1840.504--99.75rs2407992X12 920 9931308Exon 2 L669LC → G0.22500.1900.1770.379--99.16rs3747414X12 921 293300Exon 2 I769IA → C0.32210.1960.1770.225--99.07rs5744088X12 922 44511523'URTG → C0.05000.0250.0240.958--98.9^a^OMIM, Online Mendelian Inheritance in Man (<http://www.ncbi.nlm.nih.gov/Omim>)^b^SNP position in the NCBI dbSNP database (<http://www.ncbi.nlm.nih.gov/SNP>)^c^Intermarker distances, the distance between two adjacent SNP sites on the same gene sequence. The intermarker distance of first SNP was showed as "------"^d^*MAF*, minor allele frequency^e^MAF for Chinese in the NCBI dbSNPs database^f^*P* value for difference in allele distributions between tuberculosis and control group^g^*HWE* Hardy-Weinberg equilibrium in the control group^h^Genotyping Rate, rate of actual genotyping samples to total samples-: Not applicable

The genotypic frequencies of SNPs and their associations with TB risk {#Sec10}
---------------------------------------------------------------------

When investigating the TB group, the unconditional logistic regression analysis showed that 14 SNPs of *IL18R1*, *IL1A*, *STAT1*, *LTA*, *IFNGR1*, *MBL2*, *VDR*, and *IL12RB1* were associated with TB risk under a codominant model (Table S[1](#MOESM1){ref-type="media"}) and under a dominant and recessive genetic model (Table S[2](#MOESM2){ref-type="media"}). However, after adjusting for the Bonferroni correction, only SNPs in the *MBL2* gene were found to still be associated with TB risk. Therefore, we next focused on the *MBL2* gene. Our results showed that: 1) Under a codominant genetic model (Table [2](#Tab2){ref-type="table"}), the rs2099902 C/T and C/C genotypes, rs930507 C/G genotype, rs10824793 G/A and G/G genotypes, and rs7916582 T/C genotype were associated with increased risk of TB. After the Bonferroni correction, increased TB risk was still observed in patients with a rs930507 G/G genotype (*P*~*adjusted*~ = 0.027). 2) Under a dominant and recessive genetic model (Table [3](#Tab3){ref-type="table"}), the rs2099902 (C/T + C/C) vs T/T and C/C vs (T/T + C/T) genotypes, rs930507 (C/G + G/G) vs C/C genotype, rs10824793 (G/A + G/G) vs A/A as well as G/G vs (A/A + G/A) genotypes, and rs7916582 (T/C + C/C) vs T/T genotype were associated with increased risk of TB. Interestingly, increased TB risk was still observed for the rs2099902 (*P*~*adjusted*~ = 0.020), rs930507 (*P*~*adjusted*~ = 0.027), and rs10824793 (*P*~*adjusted*~ = 0.017) SNPs under a dominant genetic model after the Bonferroni correction. Table 2Genotype frequencies of SNPs in the *MBL2* gene among cases and controls and their associations with tuberculosis risk under a codominant genetic modelSNP IDGenotypeCase (TB)Control*P* (2 df)^a^Logistic RegressionNo.FrequencyNo.Frequency*OR* (95% *CI*)*P*^b^*P*~*adjusted*~^c^rs2099902T/T55255.8%32363.8%0.00251.000 (referent)C/T37237.6%16632.8%2.364 (1.317--4.244)**0.004**0.256C/C666.7%173.4%1.459 (1.143--1.863)**0.002**0.128**rs930507**C/C54957.3%33065.4%0.01491.000 (referent)C/G36337.9%15731.1%**1.556 (1.215--1.992)4.218E-40.027**G/G464.8%183.6%1.672 (0.921--3.038)0.0911.000rs10824793A/A43443.4%25951.2%0.01711.000 (referent)G/A45946.0%20640.7%1.466 (1.153--1.863)**0.002**0.128G/G10610.6%418.1%1.890 (1.245--2.870)**0.003**0.192rs7916582T/T76276.3%39879.3%0.37941.000 (referent)T/C22322.3%9719.3%1.338 (1.006--1.779)**0.045**1.000C/C141.4%71.4%1.134 (0.424--3.034)0.8031.000^a^Global *P* values (2 degrees of freedom \[df\]): genotype frequencies in tuberculosis and control group were compared using a *χ*^2^ test with two df^b^*P* values from unconditional logistic regression analyses, adjusted for age and gender^c^*P*~*adjusted*~, *P* value with Bonferroni correction, *P*~*adjusted*~ value less than 0.05 was considered to be significantTable 3Association analysis of SNPs in the *MBL2* gene under a dominant and recessive genetic modelSNP IDGenetic modelCaseControlLogistic Regression*OR* (95% *CI*)*P*^a^*P*~*adjusted*~^b^rs2099902(C/T + C/C) vs T/T438/552183/3231.544 (1.220--1.954)**3.023E-30.020**C/C vs (T/T + C/T)66/92417/4892.055 (1.154--3.659)**0.014**0.896rs930507(C/G + G/G) vs C/C409/549175/3301.568 (1.235--1.990)**2.211E-40.027**G/G vs (C/C + C/G)46/91218/4871.425 (0.790--2.568)0.2391.000rs10824793(G/A + G/G) vs A/A565/434247/2591.533 (1.219--1.927)**2.544E-40.017**G/G vs (A/A + G/A)106/89341/4651.571 (1.052--2.345)**0.027**1.000rs7916582(T/C + C/C) vs T/T237/762104/3981.324 (1.003--1.748)**0.047**1.000C/C vs (T/T + T/C)14/9857/4951.065 (0.399--2.841)0.9001.000^a^*P* values from unconditional logistic regression analyses, adjusted for age and gender^b^*P*~*adjusted*~*P* value with Bonferroni correction, the *P*~*adjusted*~ value less than 0.05 was considered to be significant

The distribution of the *MBL2* SNP genotype frequency {#Sec11}
-----------------------------------------------------

To further confirm the differences in the distribution of the *MBL2* SNP genotype frequency between the TB subgroups (TPTB, PTB, EPTB, and PTB + EPTB) and healthy controls, we performed unconditional logistic regression analysis under codominant, dominant, and recessive genetic models. The results indicated that the rs2099902 C/T and C/C genotypes, rs930507 C/G genotype, rs10824793 G/A and G/G genotypes were associated with increased TB risk in the TB subgroups (Table S[3](#MOESM3){ref-type="media"}). However, these statistically significant differences disappeared after applying the Bonferroni correction under a codominant genetic model (*P*~*adjusted*~ \> 0.05, Table S[3](#MOESM3){ref-type="media"}). A similar result was observed under the dominant and recessive genetic model (*P*~*adjusted*~ \> 0.05, Table S[4](#MOESM4){ref-type="media"}).

The distribution of the *MBL2* haplotypes and diplotypes {#Sec12}
--------------------------------------------------------

To investigate the associations regarding LD patterns between these four SNPs, we used Haploview to plot their haplotype blocks. We identified one haplotype block composed of rs10824793 and rs7916582 (*r*^2^ = 0.98). However, the rs2099902 and rs930507 SNPs in the *MBL2* gene were outside this haplotype block (Fig. [1](#Fig1){ref-type="fig"}). In the haplotype analysis, three common haplotypes (rs10824793_rs7916582\*AT, GT, and GC) were observed among the participants; the total percentage of these common haplotypes was as high as 99.85% in the TB group or 99.9% in the control group. Conversely, the total percentage of other haplotypes was only 0.15% or 0.10% in the TB or control group, respectively (Table [4](#Tab4){ref-type="table"}). The global score test indicated that the frequency of the haplotypes from the block between the TB and control groups was significantly different (global *P* = 0.00222, *P*~sim~ = 0.00207). Interestingly, statistical differences were observed in the frequency of the rs10824793_rs7916582\*AT (*P* = 0.00014) or rs10824793_rs7916582\*GT (*P* = 0.003) haplotype between the TB and control groups. Moreover, this difference remained significant after the Bonferroni correction (rs10824793_rs7916582\*AT, *P*~*adjusted*~ = 0.00042; rs10824793_rs7916582\*GT, *P*~*adjusted*~ = 0.009). Furthermore, the rs10824793_rs7916582\*GT or rs10824793_rs7916582\*GC haplotype was significantly associated with increased TB risk (*P* = 0.001, *OR*: 1.421, 95% *CI*: 1.152--1.753; or *P* = 0.018, *OR*: 1.364, 95% *CI*: 1.055--1.765) in the logistic regression analysis when compared to the rs10824793_rs7916582\*AT haplotype (Table [4](#Tab4){ref-type="table"}). Fig. 1Location and linkage disequilibrium structure for the four SNPs in the *MBL2* gene. The SNP distribution and haplotype block structure across four SNPs in the *MBL2* gene are shown, respectively. The figure was composed of chromosome-scale (the top line with even division), the transcription string (the thick bar represents exon (yellow), or UTR (grey), and the thin line represent intron), SNP scale (the hollow bar with scales representing SNPs location), and graphic of LD (black-and-green) or block definition (flammulated). Correlation coefficients (*r*^2^, × 100) are shown in the individual boxes; the color from white to red denotes *r*^2^ from 0 to 1. LD, linkage disequilibrium; UTR, Untranslated RegionsTable 4Haplotypes analysis of *MBL2* gene polymorphisms with tuberculosis riskHaplotypeTuberculosisControl*P*^a^*P*~*adjusted*~^b^Hap. Score^c^Logistic RegressionGlobal score testNo.FrequencyNo.Frequency*OR* (95% *CI*)*P*^d^Block 1: **rs10824793-rs7916582**Global-stat = 14.57143, df ^e^ = 3, *P* = 0.00222, P~sim~ = 0.00207 AT132866.3%72371.4%**0.000140.00042**−3.80391.000 (referent) GT42321.1%17717.5%**0.0030.009**2.9843**1.421 (1.152--1.753)0.001** GC24812.4%11111.0%0.0770.2311.7679**1.364 (1.055--1.765)0.018** Others30.2%10.1%----------^a^*P* value for difference in the haplotype frequency between tuberculosis and control group^b^*P*~*adjusted*~, *P* value with Bonferroni correction, *P*~*adjusted*~ value less than 0.05 was considered to be significant^c^A positive (or negative) score for a particular haplotype would have suggested that the haplotype was associated with increased (or decreased) risk of Tuberculosis^d^*P* values from unconditional logistic regression analyses, adjusted for age and gender^e^*df* degrees of freedom

Moreover, the association between the diplotypes of the *MBL2* gene polymorphisms and TB risk was also analyzed. As shown in Table [5](#Tab5){ref-type="table"}, the diplotype composed of the rs10824793_rs7916582\*AT haplotypes had a considerably decreased TB risk in a 2-copy logistic regression analysis compared with 0-copy (*P* = 0.003, *OR* = 0.530, 95% *CI*: 0.349--0.805). Moreover, this significant protective effect was still observed after Bonferroni correction (*P*~*adjusted*~ = 0.009). In contrast, increased TB risk was found in the diplotype composed of the rs10824793_rs7916582\*GT (*P* = 0.009, *OR* = 1.396, 95% *CI*: 1.087--1.793) or rs10824793_rs7916582\*GC (*P* = 0.05, *OR* = 1.330, 95% *CI*: 1.000--1.768) haplotypes in 1-copy logistic regression analysis compared with 0-copy. However, this significant difference was only observed in the diplotype composed of the rs10824793_rs7916582\*GT haplotype after Bonferroni correction (*P*~*adjusted*~ = 0.027). Table 5Diplotypes analysis of *MBL2* gene polymorphisms with tuberculosis riskHaplotype0-copy1-copy Logistic Regression2-copy Logistic RegressionCase/Control*OR* (95% *CI*)Case/Control*P*^a^*P*~*adjusted*~^b^*OR* (95% *CI*)case/control*P*^a^*P*~*adjusted*~^b^*OR* (95% *CI*)rs10824793_rs7916582\*AT106/411.000 (referent)462/2070.2350.7050.775 (0.509--1.180)433/258**0.0030.0090.530 (0.349**--**0.805)**rs10824793_rs7916582\*GT622/3451.000 (referent)335/145**0.0090.0271.396 (1.087**--**1.793)**44/160.1010.3031.684 (0.904--3.136)rs10824793_rs7916582\*GC767/4021.000 (referent)220/97**0.05**0.15**1.330 (1.000**--**1.768)**14/70.7972.3911.138 (0.426--3.041)^a^*P* values from unconditional logistic regression analyses, adjusted for age and gender^b^*P*~*adjusted*~, *P* value with Bonferroni correction, *P*~*adjusted*~ value less than 0.05 was considered to be significant

Discussion {#Sec13}
==========

In this study, we genotyped 64 SNPs from 18 IIRGs in a Han Chinese population. We first showed that the rs930507 G/G, rs2099902 \[(C/T + C/C) vs T/T\], rs930507 \[(C/G + G/G) vs C/C\], and rs10824793 \[(G/A + G/G) vs A/A\] genotypes were risk factors for TB under a codominant or dominant genetic model in TB patients and healthy controls (Fig. [2](#Fig2){ref-type="fig"}). Interestingly, these significant associations were not observed under any genetic model between subgroups of the TB patients and controls. This may be attributed to the low number of patients included in each tuberculosis subgroup. Therefore, to further improve the accuracy of the study, the sample size of each tuberculosis subgroup should be increased in the future. Fig. 2Neural network diagram of 64 SNPs in the 18 immune- and inflammation-related genes (IIRGs). The neural network diagram was plotted using an open-source graph visualization and manipulation software termed Gehpi. In the present figure, 18 genes and their SNPs were represented by solid dots. The circle size and color of the dot represent the number of connection degree, red represents the maximum connection degree, and blue represents the minimum connection degree. Three genes (*MBL2*, *LTA*, and *IL12RB1*) and their significant SNPs were showed as red color

The MBL protein is encoded by the *MBL2* gene and is secreted in the liver, where it activates the complement system via the lectin pathway to combat pathogens during host infection \[[@CR21]\]. Although the mechanisms by which the *MBL2* mutations regulate TB progression remain unclear, there is no doubt that *MBL2* plays a vital role in the pathophysiology of TB. To our knowledge, this is the first study to report that the rs930507, rs2099902, and rs10824793 polymorphisms can affect TB development in a population of Han Chinese origin. It is worth mentioning that several meta-analysis studies have reported that five *MBL2* SNPs (rs1800450, rs1800451, rs5030737, rs7095891, and rs7096206) are associated with an increased or decreased TB risk \[[@CR22]--[@CR26]\]. However, there is insufficient data regarding the role of rs930507, rs2099902, and rs10824793 in TB susceptibility. Several studies on diseases other than TB have revealed that rs930507 was associated with an increased risk of invasive pneumococcal disease (IPD) in African Americans \[[@CR27]\] and otitis media in children younger than 2 years of age \[[@CR28]\]. Moreover, it was also shown to be associated with sodium-lithium countertransport (SLC) and systolic blood pressure \[[@CR29]\]. Previous studies have found no association between rs2099902 and recurrent vulvovaginal infections risk \[[@CR30]\] or severe dengue \[[@CR31]\]; however, another study performed by Zanetti et al. suggested that rs2099902 was associated with increased risk of colon cancer in African Americans \[[@CR32]\]. These data indicate that the susceptibility and pathogenicity of the same SNP were different in various diseases. As such, the mechanisms that underlie these differences might deserve further investigation.

The above-mentioned evidence indicated an association between the *MBL2* gene and TB risk genotypes. Herein, we found an association between them by linkage disequilibrium, haplotype, and diplotype analyses. In this study (Fig. [2](#Fig2){ref-type="fig"}), the rs7916582 polymorphism was not found to be significantly associated with TB susceptibility. However, when the rs10824793 and rs7916582 SNPs were combined in haplotypes, the rs10824793\*G/rs7916582\*T and rs10824793\*G/rs7916582\*C alleles were found to be significantly associated with TB risk, which is similar to the haplotype block rs7095891\*G/rs1800450\*C/rs1800451\*C/rs4935047\*A/rs930509\*G/rs2120131\*G/rs2099902\*C yielded by LD analysis in a previous study \[[@CR31]\]. LD is the non-random combination of alleles at different loci and is influenced by several factors, such as selection, genetic drift, recombination rate, mutation rate, and population structure as well as genetic linkage. A haplotype is a group of genes in an organism that are inherited together from a single parent. Haplotypes are critical for investigating the genetics of common diseases, which have been studied in humans through the International HapMap Project \[[@CR33]\].

Analyses of polymorphism data based on LD and haplotype structure are becoming increasingly important; both have been successfully used to determine the association between *MBL2* polymorphisms and TB susceptibility. A previous study indicated that *MBL2* gene diplotypes might be significantly more common in TB patients than in the control group \[[@CR24]\]. It is well known that the haplotype or genotype information can be statistically defined as complete or incomplete data because the genotype data can be extracted from the haplotype data, but the reverse is not true. Consequently, it seems more important to determine the association between polymorphism and phenotype based on the configuration of haplotypes and diplotypes compared with alleles and genotypes. Recently, some studies have indicated that reactions to drugs and phenotypes are associated with the arrangement of haplotypes or diplotype rather than genotypes \[[@CR34]\], which is consistent with the results of our present study. Although there were no significant differences in the *MBL2* alleles observed between the TB and control groups, haplotype or diplotype configuration analysis found that the rs10824793_rs7916582\*AT/AT diplotype had a significantly decreased TB risk in 1-copy logistic regression analysis compared with 0-copy, but the rs10824793_rs7916582\*GT/GT diplotype had a considerably increased TB risk.

However, the limitation of the present study is that we did not analyze the relationship between MBL levels and TB risk. It has been reported that serum MBL levels were significantly higher in patients with active TB than in healthy controls \[[@CR35]\], which may protect against the early development of pulmonary TB after infection \[[@CR36]\].

Conclusions {#Sec14}
===========

This case-control study showed, for the first time, that the rs930507 G/G, rs2099902 (C/T + C/C) vs T/T, rs930507 (C/G + G/G) vs C/C, and rs10824793 (G/A + G/G) vs A/A genotypes were associated with an increased risk of TB in the Han Chinese population. Interestingly, our findings also showed that the rs10824793_rs7916582\*GT and rs10824793_rs7916582\*AT haplotypes or diplotypes were significantly associated with TB risk. These findings provide new insights into the association between SNPs in IIRGs and susceptibility to TB. However, it is necessary to confirm the findings of our study by performing further multi-centric clinical and extensive sample studies on different populations in China.
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**Additional file 1: Table S1.** Genotype frequencies of 64 genotyped SNPs in the *IL-10*, *IL18R1*, *IL1A*, *IL1B*, *STAT1*, *SLC11A1*, *SP110*, *IL12B*, *LTA*, *TNF*, *IFNGR1*, *MBL2*, *VDR*, *IL27*, *CCL2*, *IL12RB1*, *IFNGR2* and *TLR8* genes among cases and controls and their associations with tuberculosis risk under a codominant genetic model. **Additional file 2: Table S2.**. Association analysis of 64 SNPs in the *IL-10*, *IL18R1*, *IL1A*, *IL1B*, *STAT1*, *SLC11A1*, *SP110*, *IL12B*, *LTA*, *TNF*, *IFNGR1*, *MBL2*, *VDR*, *IL27*, *CCL2*, *IL12RB1*, *IFNGR2* and *TLR8* genes under a dominant and recessive genetic model. **Additional file 3: Table S3.** Association analysis of *MBL2* SNPs between TB subgroups and healthy controls under a codominant genetic model. **Additional file 4: Table S4.** Association analysis of *MBL2* SNPs between TB subgroups and healthy controls under a dominant and recessive genetic model.
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:   Tumor necrosis factor

TPTB

:   Total pulmonary tuberculosis

VDR

:   Vitamin D receptor

Jun-Xian Zhang and Wen-Ping Gong contributed equally to this work.

Supplementary information
=========================

**Supplementary information** accompanies this paper at 10.1186/s40249-020-00664-9.

We would like to thank the tireless contributions of the staff in the Physical Examination Center and the Institute for Tuberculosis Research, and Editage ([www.editage.cn](http://www.editage.cn)) for English language editing.

XQW was responsible for the initial conception, study design, implementation of this study, data management, and quality control. WPG was responsible for literature search, figures making, and writing for the original draft. JXZ was accountable for the implementation of this study, data management and quality control, and data analysis. HRA, WGZ, DLZ, YRY, YL, JW, and JT were responsible for organizing investigation at the study sites, data collection and data management, and comments for this draft. WPG and XQW were responsible for funding acquisition, supervision, critical revision for the original draft, and the final decision for submission. All authors contributed to reviewing and have seen and approved this manuscript for submission.

This study was funded by the Beijing Municipal Science & Technology Commission (Grant No. Z181100001718005 and 19 L2152); the National Natural Science Foundation of China (Grant No. 81801643); the Army "Twelfth Five" Scientific Research Foundation (Grant No. BWS11J050); and the Chinese PLA General Hospital (Grant No. QNC19047).

All data generated or analyzed during this study are included in this published article \[and its supplementary information files\].

The study protocol was approved by the Research Ethics Committee of the 8th Medical Center of Chinese PLA General Hospital. The signed informed consent was obtained from all participants before the investigation.

Not applicable.

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
